Advisory Research’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,275
Closed -$314K 389
2023
Q3
$314K Buy
1,275
+34
+3% +$9.3K 0.04% 364
2023
Q2
$377K Buy
+1,241
New +$345K 0.05% 343
2022
Q2
Sell
-55,182
Closed -$13.8M 399
2022
Q1
$13.8M Sell
55,182
-2,333
-4% -$586K 1.11% 23
2021
Q4
$14.8M Sell
57,515
-1,579
-3% -$386K 1.16% 21
2021
Q3
$14.3M Buy
+59,094
New +$14.4M 0.92% 33
2015
Q4
Sell
-4,348
Closed -$336K 286
2015
Q3
$336K Sell
4,348
-15,168
-78% -$1.34M ﹤0.01% 279
2015
Q2
$1.77M Buy
+19,516
New +$1.56M 0.02% 190

Other funds holding HCA

Advisory Research's HCA Position: Q4 2023 in Review

Advisory Research sold out of HCA Healthcare (HCA) in Q4 2023, closing a stake of 1,275 shares — an estimated $314K sold.

Advisory Research first reported a position in HCA in Q2 2015 and held it in 7 quarters. The position peaked at $14.8M in Q4 2021. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Advisory Research reported no remaining HCA Healthcare position as of Q4 2023 after selling out during the quarter.
  • Advisory Research sold 1,275 HCA Healthcare shares in Q4 2023, an estimated $314K.
  • Advisory Research first reported a position in HCA Healthcare in Q2 2015 and held it in 7 quarters.
  • Advisory Research's HCA Healthcare position peaked at $14.8M in Q4 2021.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Advisory Research's 13F filing for Q4 2023, filed 13 Feb 2024.